Wintrust Financial Corporation »

Intra Cellular Therapies shares owned by Wintrust Financial Corporation

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Wintrust Financial Corporation from 13F filings

Historical chart of Wintrust Financial Corporation investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Wintrust Financial Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Wintrust Financial Corporation

Quarter filed Position value Share count Share price at filing
2024-03-31 $10M 149k 69.20
2023-12-31 $11M 150k 71.62
2023-09-30 $7.9M 151k 52.09